NICOTINAMIDE HYDROCHLORIDE
- Product Name
- NICOTINAMIDE HYDROCHLORIDE
- CAS No.
- 25334-23-0
- Chemical Name
- NICOTINAMIDE HYDROCHLORIDE
- Synonyms
- NICA-001;nicotinamideHCl;Einecs 246-862-3;NIACINAMIDE HYDROCHLORIDE;NICOTINAMIDE HYDROCHLORIDE;OBLVPWTUALCMGD-UHFFFAOYSA-N;Nicotinic acid amide Hydrochloride;Niacinamide Hydrochloride|||Nicotinic acid amide Hydrochloride|||Niacinamide Hydrochloride
- CBNumber
- CB5681136
- Molecular Formula
- C6H7ClN2O
- Formula Weight
- 158.59
- MOL File
- 25334-23-0.mol
NICOTINAMIDE HYDROCHLORIDE Chemical Properties,Usage,Production
Uses
Nicotinamide Hydrochloride is a form of vitamin B3 or niacin. Nicotinamide Hydrochloride inhibits SIRT2 activity (IC50: 2 μM). Nicotinamide Hydrochloride also inhibits SIRT1. Nicotinamide Hydrochloride increases cellular NAD+, ATP, ROS levels. Nicotinamide Hydrochloride inhibits tumor growth and improves survival. Nicotinamide Hydrochloride also has anti-HBV activity[1][2][3][4].
in vivo
Nicotinamide Hydrochloride (Intraperitoneal injection, 1500 and 1800 mg/Kg, 5 days per week) inhibits tumor growth in murine metastatic melanoma model[1].
Nicotinamide Hydrochloride (Intraperitoneal injection, 1800 mg/Kg, once a day, murine metastatic melanoma model) affects IFN-γ (a key mediator of cell-mediated anti-tumor immunity), increases the plasma levels of Eotaxin and IL-5, reduces the plasma levels of IL-3, IL-12, RANTES and IL-10[1].
Nicotinamide Hydrochloride (vein injection, 0-200 mg/kg, 5 days) inhibits HBV replication in HBV-transgenic mice[3].
| Animal Model: | C57BL/6 mice (subcutaneous injected with B16-F10 cells)[1] |
| Dosage: | 1000, 1500, 1800 mg/Kg. |
| Administration: | Intraperitoneal injection, 5 days per week (followed by 2-day rest) or once a day. |
| Result: | Inhibited tumor growth at 1500 and 1800 mg/Kg, and had no effect on the body weight. Increased the frequency of IFN-γ producing cells and modulated the protein levels of cytokines and chemokines in the plasma of tumor-bearing mice. |
| Animal Model: | HBV-transgenic mice[3] |
| Dosage: | 0-200 mg/kg |
| Administration: | Vein injection, 5 days |
| Result: | Reduced serum HBV DNA. |
IC 50
Human Endogenous Metabolite; SIRT2: 2 μM (EC50); SIRT1: 50-180 μM (IC50)
References
[1] Francesca Scatozza, et al. Nicotinamide inhibits melanoma in vitro and in vivo. J Exp Clin Cancer Res. 2020 Oct 7;39(1):211. DOI:10.1186/s13046-020-01719-3
[2] Hwang ES, et al. Nicotinamide is an inhibitor of SIRT1 in vitro, but can be a stimulator in cells. Cell Mol Life Sci. 2017 Sep;74(18):3347-3362. DOI:10.1007/s00018-017-2527-8
[3] Li WY, et al. The SIRT1 inhibitor, nicotinamide, inhibits hepatitis B virus replication in vitro and in vivo. Arch Virol. 2016 Mar;161(3):621-30. DOI:10.1007/s00705-015-2712-8
[4] Zhang Y, et al. Nicotinamide promotes pancreatic differentiation through the dual inhibition of CK1 and ROCK kinases in human embryonic stem cells. Stem Cell Res Ther. 2021 Jun 25;12(1):362. DOI:10.1186/s13287-021-02426-2
NICOTINAMIDE HYDROCHLORIDE Preparation Products And Raw materials
Raw materials
Preparation Products
NICOTINAMIDE HYDROCHLORIDE Suppliers
- Tel
- 13062833949; 4006653949 4006653949
- Fax
- QQ: 2136646215
- fred.wen@crcorporation.cn
- Country
- China
- ProdList
- 9756
- Advantage
- 58
- Tel
- 15250615384
- 316228842@qq.com
- Country
- China
- ProdList
- 319
- Advantage
- 58
- Tel
- 4008200310
- marketing@tsbiochem.com
- Country
- China
- ProdList
- 24961
- Advantage
- 58
- Tel
- +86-88938639 +86-17705817739
- info@dycnchem.com
- Country
- China
- ProdList
- 53899
- Advantage
- 58
- Tel
- +17819995354
- marketing@targetmol.com
- Country
- United States
- ProdList
- 19962
- Advantage
- 58